News
OHE responds to the NHS Productivity Commission report
22 September 2026
OHE responds to the Health Foundation’s NHS Productivity Commission report, welcoming its recommendations while calling for fuller consideration of the innovation ecosystem in NHS productivity.
Financing prevention, rewriting drug pricing: the Change Initiative’s new website goes live
15 September 2026
The Office of Health Economics (OHE) has unveiled a new website for the Change Initiative, a pioneering initiative convened by the OHE, leveraging the collective expertise and insights of an expanding community of the world’s leading organisations in health and care.
OHE Deputy CEO Lotte Steuten appointed president-elect of ISPOR
26 May 2026
OHE Deputy Chief Executive Lotte Steuten has been appointed to the role of president-elect of ISPOR.
OHE responds to the King’s Speech and the proposed NHS Modernisation Bill
13 May 2026
Commenting on the King’s Speech today and the proposed NHS Modernisation Bill, Professor Graham Cookson, Chief Executive of the Office of Health Economics, said: “Today’s King’s Speech…
Atherosclerotic cardiovascular disease (ASCVD) costs the world $680 billion a year in healthcare – roughly the size of Sweden’s entire economy, new research finds
31 March 2026
The research also provides detailed, country-level insights into the health and economic costs of ASCVD across the US, Canada, UK, Netherlands, France, Germany, Spain, Italy, and Japan.
OHE responds to the 2025 UK Budget
26 November 2025
Commenting on the newly announced 2025 UK Budget, Professor Graham Cookson, Chief Executive of the Office of Health Economics, said: “The NHS’ long-term sustainability will only come…
New research reveals, in carers’ own words, the multidimensional burden of caring for leukemia patients
20 November 2025
Today, the Acute Leukemia Advocates Network (ALAN) and the Office of Health Economics (OHE published a first-of-its-kind qualitative study of informal carers across 6 countries.
New evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economy
20 October 2025
A new report published today by the Cell and Gene Therapy Catapult (CGT Catapult) and the Office of Health Economics (OHE) presents a new method of quantifying the economic impact of healthcare innovations, such as cell and gene therapies.
New OHE model estimates COVID-19 could be associated with costs of £7 billion a year in the UK, without annual autumn vaccinations
13 October 2025
A newly released report commissioned by Moderna modelled a one-year scenario without annual COVID-19 autumn vaccinations.